FBXW7/Cdc4 Antibody [DyLight 550]
Novus Biologicals, part of Bio-Techne | Catalog # NB100-93563R
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
DyLight 550 (Excitation = 562 nm, Emission = 576 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for FBXW7/Cdc4 Antibody [DyLight 550]
Immunogen
Synthetic peptide corresponding to the N terminus of isoform 2 of the FBXW7/Cdc4 protein.
Reactivity Notes
This antibody is reactive against Human
Specificity
Cdc4
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for FBXW7/Cdc4 Antibody [DyLight 550]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: FBXW7/Cdc4
Long Name
F-box and WD Repeat Domain Containing 7
Alternate Names
AGO, Archipelago Homolog, Cdc4, FBW6, Fbw7, FBX30, FBXO30, FBXW6, SCF(Fbw7), SEL10
Gene Symbol
FBXW7
Additional FBXW7/Cdc4 Products
Product Documents for FBXW7/Cdc4 Antibody [DyLight 550]
Product Specific Notices for FBXW7/Cdc4 Antibody [DyLight 550]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...